Schedule 13D ownership disclosure
RELMADA THERAPEUTICS, INC.
Security class unavailable · CUSIP: 75955J204
Event date: 2016-06-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-106396
- Form type
- SC 13D
- Filer
- LAIDLAW & COMPANY (UK) LTD.
- CIK
- CIK 1146350
- Filed
- Jun 02, 2016
- Reporting period
- Jun 01, 2016
- Description
- Schedule 13D beneficial ownership